Grimes & Company, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History

Grimes & Company, Inc.

  • $3.43 Billion
  • Q4 2024

A detailed history of Grimes & Company, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Grimes & Company, Inc. holds 2,784 shares of XBI stock, worth $243,488. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,784
Previous 2,093 33.01%
Holding current value
$243,488
Previous $206,000 21.36%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
BUY
$89.81 - $104.0 $62,058 - $71,864
691 Added 33.01%
2,784 $250,000
Q3 2024

Oct 22, 2024
BUY
$90.87 - $102.43 $190,190 - $214,385
2,093 New
2,093 $206,000
Q4 2023

Jan 24, 2024
BUY
$64.12 - $90.86 $3.9 Million - $5.52 Million
60,750 New
60,750 $5.42 Million
Q4 2018

Feb 01, 2019
SELL
N/A
-4,670 Closed
0 $0
Q3 2018

Nov 09, 2018
BUY
N/A
4,670 New
4,670 $448,000

Others Institutions Holding XBI

# of Institutions
916
Shares Held
102M
Call Options Held
27.4M
Put Options Held
38.6M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Grimes & Company, Inc. Portfolio

Follow Grimes & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email